National Infusion Center Association
- Vascular Access
- Uncategorized
- Training
- Storytelling
- Sponsored
- Scheduling
- Risk Management
- Regulatory Comment
- Providers
- Press Release
- Pharmacology
- Patients
- Operations
- Legislative Comment
- Legal Risk Mitigation
- Legal
- Insurance
- Infusion Patients
- In The News
- Emergency Resources
- Disease Management
- Data Management
- Chronic Illness
- Billing
- Artificial Intelligence
- Advocacy
- Access Issues
The National Infusion Center Association (NICA) announces its collaboration with COSACO, a community health organization based in Puerto Rico, to improve access to COVID-19 monoclonal antibody […]
“Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients” This article describes an active 80-year-old woman’s experience searching for monoclonal antibody drugs to treat her […]
“Q&A: Monoclonal Antibodies for COVID-19” In this Q&A interview with Jason C. Gallagher, PharmD, Clinical Professor and Clinical Specialist at Temple University, NICA is mentioned as […]
“Experimental COVID-19 treatment aimed at keeping Ventura County residents out of hospitals” NICA President and CEO, Brian Nyquist, is quoted in this article expressing the importance […]
“Powerful New Tool Predicts COVID Trends” This article explores predictive analytics for predicting COVID-19 surges, and NICA is mentioned as one of the organizations helping to […]
“Lower valley hospital sees success with COVID-19 antibody treatments” This article explains how one local hospital in Sunnyside, Washington successful administered monoclonal antibodies to COVID-positive patients. […]
“NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression” This article mentions that under the […]
“High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression Online Live CME Accredited Webinars” This article mentions NICA as a key resource for clinicians looking to […]
“COVID antibody treatments going unused in WA state as hospitals fill up, DOH says” As pandemic-related hospitalizations increase as a result of the Delta-variant of COVID-19, […]
By: Tiffani Bouchard, CCS Managing JW and JZ Modifiers When Billing Single-Dose Drugs Managing JW and JZ modifiers when billing single-dose drugs can be challenging. As […]
By: Pamela McIntyre, CRNI, IgCN, OCN, and VA-BC Maximizing Efficiency in Ambulatory Infusion Centers When it comes to maximizing efficiency in ambulatory infusion centers, one of […]
By: Michael Rigas, Pharm.D., FNHIA Biosimilars are also known as follow-on biologics or subsequent-entry biologics. They are FDA-approved copies of the original “innovator” drug product that […]